Table 1 Subject clinical details
Subject | DS1 | DS2 | DS3 | DS4 |
|---|---|---|---|---|
Gender | Male | Male | Male | Female |
Age | 61 | 39 | 49 | 44 |
Date of diagnostic | 13/05/96 | 01/01/90 | 01/07/87 | 01/01/91 |
Transmission type | Heterosexual | IVDU | IVDU | IVDU |
Previous ART lines | 9 | 6 | 12 | 12 |
#drugs before RAL | 13 | 9 | 13 | 12 |
New drugs started alongside RAL | DRV | DRV | DRV,ETV, T-20 | DRV,MVC |
Previous exposure | ||||
NRTI | YES | YES | YES | YES |
NNRTI | YES | YES | YES | YES |
PI | YES | YES | YES | YES |
T-20 | NO | NO | NO | NO |
ART | ddI + 3TC + DRV/r + RAL | TDF/FTC + DRV/r + RAL | TDF/FTC + DRV/r + RAL + T-20 | DRV/r + RAL + MVC |
GSS | 4 | 3.5 | 3.5 | 3.5 |
Baseline CD4 (cells/mm 3) | 614 | 300 | 332 | 399 |